ARCHIVES

Gleevec First Pediatric Cancer Approval By FDA In 13 Years

This article is from The Cancer Letter archive.

Vol. 26 No. 5 | May 30, 2003

Download PDF Visit The Full Archive

Related Articles

Clinical Societies, Patient Groups Need New Alliance, Glick Proposes to ASCO

May 24, 1996

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

July 31, 2009

Mass. Democrats, NCCS, To Provide Bracelets, Information In Honor Of Kennedy.

June 6, 2008

Three Experimental Beamlines To Be Built For Research.

May 17, 2002

Guy Newell, Anderson’s First Prevention Expert Past NCI Deputy, Dead

November 25, 1994

ASCO to form commission to study tobacco problem.

January 23, 2004